Hematology, Transfusion and Cell Therapy

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;

Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study Estela Gasparotto Emiliano; Gustavo Emmanuel Alves Abrantes Santos; Eliana Cristina Martins Miranda; Gislaine Borba Oliveira Duarte; Guilherme Brasil Duffles Amarante; Carmino Antônio De Souza; Katia Borgia Barbosa Pagnano;

Decoding BCR::ABL1 kinase domain mutations in chronic myeloid leukemia: Implications for tyrosine kinase inhibitor resistance in a South Asian population Fatima Sharif; Rafia Mahmood; Maimoona Roghani; Sikandar Hayat Khan; Ibrahim Khan;